| BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia K Srutova, N Curik, P Burda, F Savvulidi, G Silvestri, R Trotta, H Klamova, ... Haematologica 103 (12), 2016, 2018 | 40 | 2018 |
| Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating … G Silvestri, R Trotta, L Stramucci, JJ Ellis, JG Harb, P Neviani, S Wang, ... Blood cancer discovery 1 (1), 48-67, 2020 | 33 | 2020 |
| Rapid recognition of drug-resistance/sensitivity in leukemic cells by Fourier transform infrared microspectroscopy and unsupervised hierarchical cluster analysis G Bellisola, G Cinque, M Vezzalini, E Moratti, G Silvestri, S Redaelli, ... Analyst 138 (14), 3934-3945, 2013 | 30 | 2013 |
| The CAGE–MiR-181b-5p–S1PR1 Axis Regulates Anticancer Drug Resistance and Autophagy in Gastric Cancer Cells M Yeon, Y Kim, D Pathak, E Kwon, DY Kim, MS Jeong, HS Jung, ... Frontiers in cell and developmental biology 9, 666387, 2021 | 29 | 2021 |
| PI3Kδ inhibition as a potential therapeutic target in COVID-19 G Palma, T Pasqua, G Silvestri, C Rocca, P Gualtieri, A Barbieri, ... Frontiers in immunology 11, 2094, 2020 | 26 | 2020 |
| Cellular and molecular networks in chronic myeloid leukemia: the leukemic stem, progenitor and stromal cell interplay D Perrotti, G Silvestri, L Stramucci, J Yu, R Trotta Current drug targets 18 (4), 377-388, 2017 | 23 | 2017 |
| LncRNA HAS2-AS1 promotes glioblastoma proliferation by sponging miR-137 Y Lu, G Guo, R Hong, X Chen, Y Sun, F Liu, Z Zhang, X Jin, J Dong, K Yu, ... Frontiers in oncology 11, 634893, 2021 | 14 | 2021 |
| Real-time molecular monitoring in acute myeloid leukemia with circulating tumor DNA D Thakral, R Gupta, RK Sahoo, P Verma, I Kumar, S Vashishtha Frontiers in Cell and Developmental Biology 8, 604391, 2020 | 14 | 2020 |
| Comparison of SARS-CoV-2 receptors expression in primary endothelial cells and retinoic acid-differentiated human neuronal cells F Benedetti, G Silvestri, C Mavian, M Weichseldorfer, A Munawwar, ... Viruses 13 (11), 2193, 2021 | 13 | 2021 |
| Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia KME Laidlaw, S Berhan, S Liu, G Silvestri, TL Holyoake, DA Frank, ... Oncotarget 7 (32), 51651, 2016 | 13 | 2016 |
| Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients MA Ismail, M Vezzalini, H Morsi, A Abujaber, A Al Sayab, K Siveen, ... Scientific Reports 11 (1), 8833, 2021 | 10 | 2021 |
| Comment on “PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia” D Perrotti, A Agarwal, CM Lucas, G Narla, P Neviani, MD Odero, ... Science translational medicine 11 (501), eaau0416, 2019 | 9 | 2019 |
| Unsupervised explorative data analysis of normal human leukocytes and BCR/ABL positive leukemic cells mid-infrared spectra G Bellisola, MB Vittori, G Cinque, P Dumas, Z Fiorini, C Laudanna, ... Analyst 140 (13), 4407-4422, 2015 | 6 | 2015 |
| Direct and rapid identification of T315I-Mutated BCR-ABL expressing leukemic cells using infrared microspectroscopy C Sandt, O Feraud, ML Bonnet, C Desterke, R Khedhir, S Flamant, ... Biochemical and biophysical research communications 503 (3), 1861-1867, 2018 | 5 | 2018 |
| Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells. Viruses. 2021; 13 (11): 2193 F Benedetti, G Silvestri, C Mavian, M Weichseldorfer, A Munawwar, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 2 | 2021 |
| Regulative Loop between β‐Catenin and Protein Tyrosine Phosphatase Receptor Type γ (PTPRG) in Chronic Myeloid Leukemia L Tomasello, M Vezzalini, Z Fiorini, N Al‐Dewik, M Yassin, C Sorio The FASEB Journal 30, 439.11-439.11, 2016 | 2 | 2016 |
| MiR-300 acts as a tumor supressor in Ph+ progenitors by modulating the JAK2-SET/PP2A/β-catenin interplay G Silvestri, J Ellis, L Stramucci, JG Harb, P Neviani, G Marcucci, DC Roy, ... Blood 124 (21), 4529, 2014 | 2 | 2014 |
| PTPRG and BCR/ABL1 expression in CML patients at diagnosis and upon TKI treatment: Preliminary results M Monne, G Piras, M Vezzalini, A Uras, M Murineddu, MA Yassin, ... Blood 122 (21), 5163, 2013 | 2 | 2013 |
| Mycoplasma DnaK expression increases cancer development in vivo upon DNA damage F Benedetti, G Silvestri, F Denaro, G Finesso, R Contreras-Galindo, ... Proceedings of the National Academy of Sciences 121 (10), e2320859121, 2024 | 1 | 2024 |
| CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment B Buldini, E Varotto, M Maurer-Granofszky, G Gaipa, A Schumich, ... Blood, 2024 | 1 | 2024 |
Perrotti DaniloThe University of Maryland BaltimoreVerified email at som.umaryland.edu
